Marek's disease virus vaccines for protection against Marek's disease
US6322780A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Sep 9, 1996 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Sep 9, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nucleotide sequence encoding the gp82 polypeptide of Marek's disease virus is disclosed. Also disclosed are recombinant viruses which are useful as vaccines for protecting against Marek's Disease, preferably containing two or more genes encoding Marek's Disease Virus antigens such as glycoprotein B and glycoprotein gp82, under the control of a poxvirus promoter within a region of the DNA of fowlpox virus which is not essential for virus growth. Also provided is a vaccine exhibiting a synergistic immunoprotective effect, comprising a recombinant fowlpox virus expressing Marek's Disease Virus gB protein in combination with turkey herpesvirus. A method of immunizing poultry, comprising administering any of the disclosed vaccines, is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.